Fluoroquinolones-related psychiatric adverse events: a real‑world retrospective and pharmacovigilance database analysis

Objective The purpose of this study was to evaluate the pharmacovigilance and clinical characteristics of psychiatric adverse events(AEs) related to Fluoroquinolones(FQs), and to determine the risk factors for timely management.